Teleperformance SE (0J6X)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 75.47 |
|---|---|
| 52-week range | 42.04 – 76.92 |
| Return, 1 month / 3 months | +9.1% / +42.4% |
| Return, 1 year / 3 years | +28.7% / −22.6% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 49.6% |
| Worst drawdown (1 year) | -35.4% |
| Average daily value traded | 1.09M EUR |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Teleperformance is a provider of outsourced customer experience and business process services, based in France. The company runs contact centres and digital support operations for clients across sectors such as technology, telecommunications, banking, healthcare and travel. Its staff handle customer enquiries by phone, chat, email and social media, and it also offers back-office services including technical support, collections and content moderation. It serves large organisations that choose to outsource parts of their customer service and administrative work.
On this site Teleperformance SE appears as a stock on the London Exchange (UK), code 0J6X, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Teleperformance SE (0J6X) trades on the London Exchange in UK. It last closed at EUR 75.47 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 728 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.7% and over the last three months it rose 42.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 29.9% | ||
| From 52-week high | -1.3% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 42.4% | ||
| 6-month return | 43.8% | ||
| 12-month return, skipping the last month | 17.9% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.4% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +9.1% |
| 3 months | +42.4% |
| 6 months | +43.8% |
| 1 year | +28.7% |
| 3 years | −22.6% |
| 5 years | −74.3% |
Signals
| 50-day / 200-day average | 70.80 / 58.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 4.5000 |
| 23 May 2025 | EUR 4.2000 |
| 28 May 2024 | EUR 3.8500 |
| 21 Apr 2023 | EUR 3.8500 |
| 26 Apr 2022 | EUR 3.3000 |
| 27 Apr 2021 | EUR 2.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.